Venous Thrombosis Clinical Trial
Official title:
Long Term Outcomes of Venous Thromboembolism -the LOVE Study-
This prospective observational follow-up study is designed to assess the long-term outcomes
after Venous thromboembolism (VTE) and to assess the effect of the new oral anticoagulant
(NOAC) rivaroxaban on the prevalence of post-thrombotic syndrome (PTS).
The study will not be testing any formal hypothesis.
This prospective observational follow-up study is designed to assess the long-term outcomes
after VTE and to assess the effect of NOAC (rivaroxaban) on the prevalence of PTS. All
patients diagnosed and treated for VTE at SØF from 01.01.2011 will be invited to participate
in this study. Newly diagnosed patients will be recruited and followed-up according to the
study schedule which is based on state of the art international guidelines.
First follow-up will be performed at the end of treatment period, which is usually 3 or 6
months after an event of VTE, or at one year if patients will be put on permanent AC.
Thereafter, patients will be followed-up annually for at least 5 years or up to the end of
the study, i.e for 10 years.
The primary endpoints of the study are the development of PTS and CTEPH after VTE. There
will be 3 visits: at 3 or 6 months depending on the duration of AC, at 2 and 5 years, in
addition to a visit for TTE at 6 months. Remaining follow-ups will be performed by phone or
by mail. All patients with PE will be examined by TTE 6 months after the diagnosis of PE.
Those with signs of PAH will be referred for further work-up to establish the presence or
absence of CTEPH at specialized centres. Patients with DVT will be evaluated for PTS at 2
and 5 years and for CTEPH if they develop dyspnoea. As for part b of the primary objective,
the study will allow inclusion of patients with previous DVT diagnosed after 01.01.11.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02567903 -
Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System
|
N/A | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Recruiting |
NCT02650453 -
Ongoing Registry of Deep Venous Reconstructions
|
N/A | |
Completed |
NCT00839657 -
Clarification of Optimal Anticoagulation Through Genetics
|
Phase 3 | |
Completed |
NCT02065388 -
Pharmacogenetic Dosing of Warfarin
|
Phase 3 | |
Terminated |
NCT00872079 -
Personalized Warfarin Dosing by Genomics and Computational Intelligence
|
N/A | |
Terminated |
NCT00521885 -
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
|
N/A | |
Completed |
NCT00346424 -
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
|
Phase 3 | |
Completed |
NCT02892565 -
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
|
N/A | |
Active, not recruiting |
NCT04349189 -
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
|
||
Recruiting |
NCT02238444 -
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
|
Phase 4 | |
Recruiting |
NCT02597218 -
Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.
|
||
Completed |
NCT00986154 -
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
|
Phase 3 | |
Completed |
NCT00246025 -
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
|
Phase 2 | |
Completed |
NCT00097357 -
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
|
Phase 2/Phase 3 | |
Completed |
NCT04645550 -
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
|
Phase 4 | |
Recruiting |
NCT02264743 -
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
|
Phase 4 | |
Completed |
NCT01482273 -
Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis
|
N/A | |
Recruiting |
NCT01252420 -
Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
|
Phase 4 | |
Completed |
NCT01145859 -
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
|
Phase 1 |